Athersys Reports First Quarter 2018 Results
May 10, 2018 16:03 ET
|
Athersys, Inc.
CLEVELAND, May 10, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today its financial results for the three months ended March 31, 2018. Highlights of the first quarter of 2018 and...
Athersys and Healios Extend by One Month the Period to Complete Collaboration Expansion Agreements
May 01, 2018 06:00 ET
|
Athersys, Inc.; Healios
CLEVELAND and TOKYO, May 01, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) and HEALIOS K.K. (“Healios”) (TSE Mothers Code:4593) have agreed to extend the period from April 30, 2018 to May...
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients
April 23, 2018 06:00 ET
|
Athersys, Inc.
CLEVELAND, April 23, 2018 (GLOBE NEWSWIRE) -- The University of Texas Health Science Center at Houston (UTHealth) and Athersys, Inc. (NASDAQ:ATHX) today announced plans to conduct a Phase 2 clinical...
Athersys to Host First Quarter Financial Results Call
April 12, 2018 16:00 ET
|
Athersys, Inc.
CLEVELAND, April 12, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018, and...
Athersys to Present at Needham Healthcare Conference on March 28
March 20, 2018 13:00 ET
|
Athersys, Inc.
CLEVELAND, March 20, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 17th Annual Needham...
Athersys Reports Financial Results for Fourth Quarter, Full Year 2017
March 13, 2018 16:05 ET
|
Athersys, Inc.
Company also announces equity investment and binding letter of intent to expand HEALIOS K.K. collaboration, covered in a separate release Management to host conference call at 4:30 PM EDT today ...
Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration
March 13, 2018 06:00 ET
|
Athersys, Inc.
Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated...
Athersys and Healios Announce Binding Letter of Intent to Expand MultiStem® Collaboration
March 13, 2018 02:30 ET
|
Athersys, Inc.
Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated...
Athersys to Host Year-End 2017 Financial Results Call
February 12, 2018 13:30 ET
|
Athersys, Inc.
CLEVELAND, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its year-end 2017 financial results at approximately 4:00 PM Eastern Time on Tuesday, March 13, 2018, and will...
Athersys Enters Into New $100 Million Equity Facility with Aspire Capital
February 02, 2018 06:00 ET
|
Athersys, Inc.
Provides access to capital to support ongoing business and development objectives CLEVELAND, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) and Aspire Capital Fund, LLC (“Aspire...